Role of endogenous cholecystokinin on growth of human pancreatic cancer
Open Access
- 1 March 2011
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 38 (3), 593-601
- https://doi.org/10.3892/ijo.2010.886
Abstract
Cholecystokinin (CCK) and gastrin stimulate growth of pancreatic cancer. Although down-regulation of gastrin inhibits growth of pancreatic cancer, the contribution of endogenous CCK to tumor growth is unknown. The purpose of this study was to evaluate the role of endogenous CCK on autocrine growth of pancreatic cancer. Pancreatic cancer cell lines were analyzed for CCK mRNA and peptide expression by real-time RT-PCR and radioimmunoassay, respectively. The effect of endogenous CCK on growth was evaluated by treating cancer cells with CCK neutralizing antibodies and by down-regulating CCK mRNA by RNAi. Wild-type pancreatic cancer cells expressed significantly lower CCK mRNA and peptide levels than gastrin. Neither treatment of pancreatic cancer cells with CCK antibodies nor the down-regulation of CCK mRNA and peptide by shRNAs altered growth in vitro or in vivo. Conversely, when gastrin mRNA expression was down-regulated, the same cells failed to produce tumors in spite of having sustained levels of endogenous CCK. Pancreatic cancer cells produce CCK and gastrin; however, the autocrine production of gastrin is more important for stimulating tumor growth.Keywords
This publication has 25 references indexed in Scilit:
- Growth of Human Pancreatic Cancer Is Inhibited by Down-Regulation of Gastrin Gene ExpressionPancreas, 2009
- Inducing apoptosis and enhancing chemosensitivity to Gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cellCancer Chemotherapy and Pharmacology, 2008
- Role of gastrin peptides in carcinogenesisCancer Letters, 2007
- Cholecystokinin Down-Regulation by RNA Interference Impairs Ewing Tumor GrowthClinical Cancer Research, 2007
- Prospects of RNA interference therapy for cancerGene Therapy, 2005
- Characterization of the CCK-C (cancer) receptor in human pancreatic cancer.International Journal of Molecular Medicine, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Closing the gastrin loop in pancreatic carcinomaCancer, 2000
- Ceramide Inhibits Protein Kinase B/Akt by Promoting Dephosphorylation of Serine 473Published by Elsevier BV ,2000
- Quantitative analysis of gastrin mRNA and peptide in normal and cancerous human pancreas.International Journal of Molecular Medicine, 1998